Volume 15, Number 12—December 2009
A Groundhog, a Novel Bartonella Sequence, and My Father’s Death
On This Page
- Initial Hospitalization
- Second Hospitalization
- Translational Research and the Practice of Medicine
- Clinicians and Scientists Working Together
- Home Again at Last
- Third and Final Hospitalization
- A Battle Lost
- Groundhogs, Fleas, and the Genus Bartonella
- Age, Bartonella spp., and Immune Suppression?
- Ecologic Complexity of Bartonella spp.
- Occult Infection and Chronic Illness
- My Father and “One Medicine”
- Cite This Article
Highlight and copy the desired format.
|EID||Breitschwerdt EB, Maggi RG, Cadenas MB, Diniz PP. A Groundhog, a Novel Bartonella Sequence, and My Father’s Death. Emerg Infect Dis. 2009;15(12):2080-2086. https://dx.doi.org/10.3201/eid1512.AD1512|
|AMA||Breitschwerdt EB, Maggi RG, Cadenas MB, et al. A Groundhog, a Novel Bartonella Sequence, and My Father’s Death. Emerging Infectious Diseases. 2009;15(12):2080-2086. doi:10.3201/eid1512.AD1512.|
|APA||Breitschwerdt, E. B., Maggi, R. G., Cadenas, M. B., & Diniz, P. P. (2009). A Groundhog, a Novel Bartonella Sequence, and My Father’s Death. Emerging Infectious Diseases, 15(12), 2080-2086. https://dx.doi.org/10.3201/eid1512.AD1512.|
During the summer of 2007, migratory joint pain developed in my (E.B.B.) 86-year-old father, previously an ironworker, farmer, and World War II veteran. Because of occasional tick attachments, a Borrelia burgdorferi ELISA was performed; antibodies were not detected, and no treatment was instituted. In the fall, subtle memory loss developed, and he fell twice a few weeks apart. Dad jokingly blamed the falls and the memory loss on “old timer’s disease.” Subsequently, episodes of subtle confusion and more frequent memory loss generated family concern as to what the future might hold. On December 15, he broke his left femur during a fall while climbing 2 stairs to enter our home. Despite having successfully climbed those stairs thousands of times in the past, he would never climb those or any other stairs again.
Retrospectively obvious, a pattern of insidious illness characterized by joint pain, memory loss, and incoordination, not recognizable by my father or other family members, had begun before that summer. Medically stable historical problems included coronary artery disease, atherosclerosis, carotid artery occlusion, hypertension, and atrial fibrillation. During the previous year, a normocytic, normochromic, nonregenerative anemia persisted. Despite normal serum iron, total iron binding capacity, ferritin, and vitamin B12 values, anemia was attributed to intestinal blood loss. When examined in May 2007, before anesthesia for endoscopy, mood and affect were appropriate, recent and remote memory were intact, insight and judgment were good. A hiatal hernia, mild antral gastritis, and duodenitis were visualized.
When my father was hospitalized December 15, 2007, with a broken femur, a resting pill roll tremor and cogwheel rigidity were suggestive of Parkinson disease. Preoperative neurologic consultation identified severe confusion, inattention, and an inability to answer questions. Short-term memory and problem-solving abilities were decreased. There was mild ptosis of the right eye, normal cranial nerves, mild asterixis, and hand weakness. Laboratory abnormalities included anemia, hypercreatinemia, an elevated aspartate aminotransferase level, and hyperglobulinemia. Due to the severity of the femoral fracture, the femoral head was excised and replaced with a bipolar femoral prosthesis.
Postoperatively, poor mentation was considered a sequela of general anesthesia and peri-operative analgesics. For more than a week, dementia persisted. He did not recognize family members and had near constant hallucinogenic activities, including agitation, tying knots, sawing motions, and constantly pulling covers, bed clothes, and fluid lines. Severe hematuria developed after he pulled an inflated Foley catheter from his urethra. Concurrent gastrointestinal bleeding of undetermined cause necessitated multiple blood transfusions. Other complications included difficulty swallowing and paralytic ileus. Repeat abdominal radiographs, in conjunction with stool softeners and laxatives, failed to alleviate gastrointestinal complications. Eventually, he refused food and became severely bloated. Endoscopy performed on December 26 identified severe necrotizing esophagitis, multiple plaques, and a stricture attributed to Candida albicans and herpes zoster. C. albicans esophagitis is known to accompany HIV infection, leukemia, or an unidentified source of immune suppression (1,2). Shingles, caused by herpes zoster, occurred during the previous Thanksgiving and can be associated with immunosuppression, stress, or an aging immune system (3,4). Mentation and gastrointestinal abnormalities improved after starting treatment with fluconazole, acyclovir, and symptomatic medications for erosive esophagitis. However, confusion, lack of orientation, hyponatremia, hypokalemia, and hyperglycemia remained problematic until discharge to a physical therapy center on December 31.
During the next week, strength and mental capacities improved rapidly and discharge to the home environment was scheduled for January 9. On that morning and while driving to Maryland to build entry ramps, I was informed by cell phone that my father fell out of a chair and became nonverbal and that a stroke was suspected. For me, the roller coaster illness ultimately leading to his death would take an unbelievable turn of events. Upon his transfer to the neurology service, encephalopathy, asterixis, Parkinsonian-type tremor, hypoactive reflexes, pinpoint and minimally reactive pupils, and cogwheel rigidity were found. Verbal communication was absent, but he would grimace with pain whenever extremities were manipulated. An urgent computed tomography scan did not identify intracranial abnormalities.
When I was a boy, my father used the expression “something is fishy in Denmark” to imply that something was astray. Based upon historical events, I suspected something was being missed. Laboratory findings included anemia (hemocrit 34%), a normal leukogram (leukocytes 9,100 cells/μL, 2% band neutrophils), mild hypokalemia, hypoalbuminemia, hyperglycemia, increased serum alkaline phosphatase level, erythrocyte sedimentation rate of 79, and hypergammaglobulinemia. Thoracic radiographs identified mild bilateral pleural effusion. Because an undefined infectious source of immunosuppression seemed plausible, and fever (maximum temperature 38.6°C) occurred 24 hours after neurologic decompensation an infectious etiology was pursued. Nasal methicillin-resistant Staphylococcus aureus, blood, urine, and cerebrospinal fluid (CSF) cultures were negative. CSF results, including those for special stains, were unremarkable. Serologic results for Treponema pallidum, Borrelia burgdorferi, Rickettsia rickettsii, Bartonella henselae, Bartonella quintana, and HIV were negative. Results of CSF herpes simplex PCR and a test for T. pallidum antibodies were negative.
On January 11, results of magnetic resonance imaging and magnetic resonance angiography were interpreted as a left posterior stroke with no active bleeding. Initial treatment included intravenous acyclovir, fluconazole, vancomycin, ceftriaxone, ampicillin, and dexamethasone.
Because I direct the Intracellular Pathogens Research Laboratory (IPRL) at the North Carolina State University College of Veterinary Medicine, aseptically obtained blood and CSF samples were kindly provided for testing. Results of PCR (5,6) specific for Anaplasma, Ehrlichia, and Rickettsia species were negative. Bartonella 16S–23S intergenic spacer primers (7) repeatedly generated amplicons of different sizes from blood and CSF, respectively. Compared with GenBank sequences, the blood amplicon was most similar (434/465bp) to Candidatus Bartonella volans (strain FSq-1, EU294521) isolated from a southern flying squirrel (Glaucomys volans) and Candidatus Bartonella durdenii (391/422bp) amplified from Orchopeas howardi (GenBank accession no. DQ 336386), a flea found on eastern US gray squirrels (Scinrus carolinensis), and a Bartonella sp. (446/492bp, EF125214) identified in ground squirrels (Spermophilus danricus) in the People’s Republic of China. The novel rodent Bartonella sequence obtained from my father’s blood had an 18-bp insert at positions 2047 or 334 in EU294521 and DQ336386, respectively. Previously, our laboratory had never worked with rodent Bartonella species and had never amplified a 300-bp internal transcribed spacer region amplicon from >3,000 animal or human blood samples. After several unsuccessful cloning attempts, the CSF amplicon was most similar (393/394 bp) to B. henselae (NC-005956). Blood and CSF, cultured by using Bartonella α Proteobacteria growth medium (BAPGM) (8), did not result in the growth of a Bartonella species.
After Bartonella PCR results became available, treatment with piperacillin and tazobactam were continued for 3 weeks until discharge. Levetiracetam was added to the patient’s treatment because a generalized seizure occurred shortly after antimicrobial drugs were given. On January 18, severe dependent edema of the right elbow resulted in fluid leakage through intact skin. For 3 weeks, Dad remained semicomatose, disoriented, agitated, and encephalopathic. Hallucinations continued, accompanied by frequent involuntary motor movements. Diabetes mellitus and a large decubital ulcer on the right heel developed. During the fourth week, mentation improved, and he could rise and stand for brief periods. On January 28, he was discharged to a rehabilitation facility, with instructions to receive doxycycline and rifampin 2×/d for 13 days. Blood samples, obtained aseptically before discharge, were again submitted to the IPRL. After BAPGM pre-enrichment and subculture, B. vinsonii subsp. berkhoffii genotype II was isolated, and sequential serologic testing identified a rising titer to B. vinsonii subsp. berkhoffii but did not detect B. henselae antibodies (Table). After a brief, emotionally traumatic stay at the rehabilitation facility, Dad returned home to be cared for by 4 sons, his wife of 60 years, and other family members. Each week a different son slept by his bed, which was relocated to the family living room.
During the next 3 weeks, there was substantial and progressive improvement in physical capabilities and a return of normal mental capabilities, including exceptional short- and long-term memory. Appetite normalized, and despite severe atrophy, muscle strength increased so he could stand, walk with assistance, and, although a daily struggle, access the bathroom. A February 10 blood sample obtained while he was receiving oral antimicrobial drugs was Bartonella PCR negative, and no bacteria were isolated in BAPGM. During this precious 3 weeks, our father joked, laughed, and vividly recalled wartime friends and other experiences. On March 1, 2008, he opened Christmas presents with our family. I should have been there.
On March 4, ≈2 weeks after the course of oral antibiotics was completed, agitation and disorientation returned, and mental status deteriorated. Within 24 hours, Dad was hospitalized, where fine motor tremors of the right hand and wrist, asymmetric edema involving the right leg, and edema of the penis and scrotum were noted. He was afebrile and nonverbal and could not follow simple commands. Hematocrit was 30.2%, platelet count 557,000 cells/μL, and leukocyte count 7,800 cells/μL with a normal differential count. Serum biochemical abnormalities included hyperglycemia (glucose 218 mg/dL), hyperglobulinemia (3.6 g/dL), and increased alkaline phosphatase activity (169 IU/L). Urinalysis abnormalities included proteinuria with occasional hyaline casts.
Lorazepam was administered to control the agitation and restlessness. The warfarin dose was increased and heparinization initiated for a potential cerebrovascular accident. Due to the prior documentation of Bartonella infection, intravenous doxycycline, rifampin, and gentamicin were administered, and total parenteral nutrition was instituted. Again, shortly after initiation of antimicrobial drugs, a seizure occurred. Bartonella spp. were not amplified or isolated from a 1-mL blood sample obtained 4 days after initiation of treatment with antimicrobial drugs. During the next 3 weeks, while intravenous antimicrobial drugs were administered, our father again remained encephalopathic, with frequent hallucinations, severe agitation, and near-constant mental confusion. On March 14, intravenous methylprednisolone for potential immune-mediated vasculitis elicited no improvement in mental status. Similar to the previous treatment course, improvement in mental status, coherent communication, and renewed ability to recognize family members occurred during the fourth hospitalization week.
On April 4, Dad was discharged to our home and oral antimicrobial drugs (doxycycline and rifampin) were dispensed. Despite all efforts by medical professionals, members of our family, and our tough 86-year-old father, protracted illness and prolonged hospitalizations had resulted in mental and physical debilitation, severe muscle wasting, and profound weakness. More important, he had lost his desire to live. After discharge, there was minimal neurologic improvement. Before the availability of April 4 IPRL test results, he began to refuse all medications. The identical rodent Bartonella DNA sequence was again amplified from his blood, but no bacteria were isolated.
Four weeks later my father died, on Friday, May 2, at 5
Following our father’s death, I recalled a small, 0.5-cm, raised, firm lesion within his right eyebrow that developed during the summer of 2007 and would spontaneously hurt or burn, causing him to rub or squeeze the lesion. The mass disappeared after he began taking antimicrobial drugs in 2008. Retrospectively, I suspected a rodent flea bite above the eye had transmitted a novel Bartonella species, which we sequenced from his blood after each hospitalization. All known Bartonella spp. have preferential animal reservoir hosts, and each uses arthropods or animal bites and scratches as the primary modes of transmission (10–12). Dad would occasionally capture mice, rats, skunks, and groundhogs in the barns. Groundhogs were transported in the car trunk to a distant location for release, potentially leaving behind fleas. Therefore, 3 Candidatus Bartonella spp. isolates were provided by Dr. William Nicholson, a colleague at the Centers for Disease Control and Prevention in Atlanta. After sequencing, the 16S–23S intergenic spacer region of a ground squirrel (Candidatus Bartonella durdenii), a flying squirrel (Candidatus Bartonella volans), and a groundhog (Candidatus Bartonella monaxi) isolate, the most similar GenBank sequence was Candidatus Bartonella volans. There was no perfect match with these 3 isolates. However, sequences from Dad’s blood clustered with a squirrel Bartonella subgroup. This observation supports the presence of a novel Bartonella species on the eastern shore of Maryland, an as yet undefined animal reservoir, and an unknown arthropod vector.
Regardless of the mode(s) of transmission, repeated molecular documentation of a novel rodent Bartonella sp. and B. vinsonii subsp. berkhoffii supports the unexpected failure of 2 intensive courses of intravenous and oral antimicrobial drugs to eliminate these fastidious, intravascular bacteria. During the first two hospitalization periods, there was similar and progressive improvement in neurologic signs and mental capabilities that began during the fourth week of antimicrobial drug administration. Pre-enrichment BAPGM growth of B. vinsonii subsp. berkhoffii from blood obtained 4 days before death supports persistence of viable organisms. Recently, antimicrobial drug resistance genes have been characterized in B. bacilliformis, B. henselae, and B. quintana by in vitro serial passage (13–15). Retrospectively, the relapse in encephalopathic signs might have been avoided if antimicrobial drugs were continued for a longer interval after discharge from hospital 2, and blood cultures were optimally obtained and sequentially tested to confirm therapeutic elimination.
Elimination of Bartonella spp. by antimicrobial drugs in immunocompetent patients may be more difficult to achieve than is currently appreciated (16). Although co-infection with B. henselae and B. vinsonii subsp. berkhoffii has been previously reported, DNA of 3 Bartonella spp. was detected in our father. Based on repeatable PCR testing, a small quantity of B. henselae DNA was in the January CSF sample. Because PCR amplicon contamination was never detected in any negative control, laboratory error is considered unlikely. Although the BAPGM enrichment approach has improved molecular detection and isolation of some Bartonella spp. from human patient samples (9,16–18), a rodent Bartonella sp. isolate was not obtained. Unfortunately, 8 weeks can be required from inoculation of BAPGM until a subculture agar plate isolate is characterized by DNA sequencing. Therefore, IPRL test results were often not available to Dad’s physicians in a timely manner.
Suspicion of an undetermined source of immune suppression and recent tick exposures were primary factors motivating testing in the IPRL. Previously, B. vinsonii subsp. berkhoffii was shown to induce immunosuppression in experimentally infected dogs (19,20). In retrospect, occult infection with Bartonella spp. may have contributed to shingles at Thanksgiving and necrotizing C. albicans esophagitis after hospitalization for the fractured femur. Recently, B. quintana lipopolysaccharide was found to have antiinflammatory properties (21). Immune suppressive factors may facilitate persistent intravascular Bartonella infection without inducing obvious infection indicators, such as fever, tachycardia, leukocytosis, and CSF pleocytosis. Fever was documented once and mild neutrophilia for 3 of 48 blood counts. Thrombocytosis, previously associated with B. henselae (22), was documented 14 times.
Because of my father’s long-standing atherosclerosis and because BAPGM will grow a spectrum of seemingly difficult to isolate bacteria (8,23), pre-enrichment blood cultures and Bartonella internal transcribed spacer region PCR had been performed in September 2005 and August 2006 (Table). Bartonella spp. were not amplified or isolated, which suggests infection occurred after the summer of 2006. Transmission of B. henselae, B. vinsonii subsp. berkhoffii, and B. alsatica can occur as a result of a scratch from a cat, a dog, or a wild rabbit, respectively (17,24–26). Cats are the primary reservoir for B. henselae, whereas dogs and coyotes are the only reported reservoir hosts for B. vinsonii subsp. berkhoffii genotype II in North America (27). Recently, B. vinsonii subsp. berkhoffii genotype II was isolated by BAPGM blood culture from a cat with recurrent osteomyelitis (E.B. Breitschwerdt, unpub. data), which suggests that a bacteremic cat might facilitate transmission of this subspecies. My parents had an old (≈21 years of age) exclusively outdoor barn cat that would occasionally scratch. The cat could not be tested because it died in 2007. B. henselae and B. clarridgeae have been transmitted experimentally by transfusion to cats (24). Because B. vinsonii subsp. berkhoffii seroconversion occurred during hospitalization, transfusion-associated transmission is also possible. The exact timing and mode of transmission of B. henselae, B. vinsonii subsp. berkhoffii, and the rodent Bartonella sp. to our father cannot be established. However, his illness serves to illustrate the medical and ecologic complexity of this genus.
Reconstructing the history of a chronic illness is always difficult and remains an unexacting science due to known, unknown, and undetermined factors that influence disease expression over time. Experimental studies that used rodent models have emphasized the ability of Bartonella spp. to invade erythrocytes and vascular endothelial cells (28). In vitro studies indicate that B. henselae can infect macrophages, microgial cells, dendritic cells, and CD34+ progenitor cells (29). B. henselae and B. vinsonii subsp. berkhoffii have been amplified from dog lymph node aspiration samples (30). Thus in a given patient, Bartonella organisms likely infect a substantial number of cellular targets. B. henselae infection induces chronic arthritis in a subset of cat scratch disease (CSD) patients, and atypical CSD manifestations are more likely to develop in elderly patients (31,32). In the context of arthritis, B. henselae and B. vinsonii subsp. berkhoffii were repeatedly isolated from joint fluid from a dog in which repeated antimicrobial drug therapy was not successful (33). Although a spectrum of acute and generally self-limiting neurologic manifestations have been historically described in CSD patients, B. henselae and B. vinsonii subsp. berkhoffii were only recently isolated from patients with chronic neurologic and neurocognitive abnormalities (16).
We propose that the initial arthritic signs, short-term memory loss, and incoordination were premonitory signs of Bartonella spp. infection, and that persistent infection contributed to localized edema, nonregenerative anemia, thrombocytosis, hyperglobulinemia, and a protracted debilitating illness accompanied by hallucinations, agitation, seizures, and death. Agitation, disorientation, and combative behavior have been reported in association with CSD and physicians have implicated Bartonella spp. as contributors to agitation and treatment-resistant depression (34,35). Memory loss and a spectrum of neurocognitive complaints have also been reported in immunocompetent persons infected with B. vinsonii subsp. berkhoffii and B. henselae (9,16,17).
In recent years, there has been renewed interest in the concept of “One Medicine” (36). I hope that lessons from my father’s death can reinforce the importance of “One Medicine.” However, as in the past, rhetoric may not result in needed increases in resource allocation to enhance educational, research, service, and public health capabilities of the veterinary profession (37). In the context of vector-borne infectious diseases, zoonotic diseases, food safety, zoologic medicine, and environmental medicine and ecosystem health, to name a few areas, veterinarians continue to make major contributions that ensure and enhance the daily health of animals and humans. Because of a research focus in comparative infectious diseases and knowledge of the biologic, immunologic, and pathophysiologic behavior of Bartonella spp. in a spectrum of animal species, a veterinary research laboratory was able to assist with the management of my father’s illness.
As is often true of research at the bedside and the laboratory bench, new lessons and challenges arose from the collective efforts of doctors, nurses, veterinarians, research scientists, and others attempting to heal my father. I and my family remain sincerely grateful to the many doctors, nurses, and other caregivers who contributed to the management of my father’s surgical and medical problems. Because of the severe encephalopathic and combative nature of his behavior, this was frequently not an easy or pleasant task. During his illness, I was struck by several items: 1) most nurses are absolutely amazing, caring, and dedicated professionals; 2) in human medicine, unlike veterinary medicine, no physician claimed or accepted the responsibility to be my father’s doctor; and 3) for many reasons, I found the human healthcare system to be frayed, if not broken. Whether blame lies with the insurance companies, our litigious society, the profit-based motivations of hospital administration, the increased complexity of medical technology, or the medical education of physicians, it really does not matter. As my father would say, “It is no way to do business.” I have taught internal medicine at a College of Veterinary Medicine for 32 years. During that time, every sick animal on our medical service had at least 2 doctors (1 being a student), who were directly responsible for the animal’s care, for frequent communications with the owner, and for communications with the referring veterinarian. In our increasingly complex hospital environments, every patient needs a personal advocate or designated doctor to represent his or her interests.
Some years ago in a conversation with my mother I suggested that the term natural death may well represent an oversimplification of the processes that end a person’s life. My father and our family were substantially affected during his illness. Each day, from initial hospitalization until his death, there was at least 1 family member at his side. In the eyes of family and friends, my father was a great man in so many respects. He was a loving husband, a caring father, diligent worker, and a friend and supporter to many persons. Potentially, his illness illustrates a complex interaction between intravascular Bartonella infection and complex disease expression, provides documentation for an as yet uncharacterized zoonotic rodent Bartonella sp., and offers disconcerting evidence supporting antimicrobial drug ineffectiveness and clinical evidence supporting the concept that persistent infection with >1 Bartonella spp. may lead to immunosuppression and opportunistic infections with organisms such as herpes zoster and C. albicans. As in his life, Dad would want this story to benefit others after his death. We hope that it does.
Dr Breitschwerdt is a professor of medicine and director of the Intracellular Pathogens Research Laboratory, Center for Comparative Medicine and Translational Research, College of Veterinary Medicine, North Carolina State University, Raleigh, NC. His research interests include diagnosis and treatment of vector-borne intracellular pathogens.
We thank William Nicholson for providing the Candidatus Bartonella isolates for comparative DNA sequencing, Natalie Cherry for sequencing the internal transcribed spacer region of the 3 Candidatus isolates, Julie Bradley for performing serologic testing, Barbara Hegarty for preparing Bartonella antigens, and Tonya Lee for providing editorial assistance.
- Manfredi R, Sabbatani S, Calza L. Recurring Candida albicans esophagitis in a HIV-infected patient undergoing long-term antiretroviral therapy, and with absent-negligible immunodeficiency. Braz J Infect Dis. 2007;11:605–9.
- Klingspor L, Stintzing G, Tollemar J. Deep Candida infection in children with leukaemia: clinical presentations, diagnosis and outcome. Acta Paediatr. 1997;86:30–6.
- Schmader KE, Dworkin RH. Natural history and treatment of herpes zoster. J Pain. 2008;9:S3–9.
- Schmader K. Herpes zoster in the elderly: issues related to geriatrics. Clin Infect Dis. 1999;28:736–9.
- Kidd L, Maggi R, Diniz PP, Hegarty B, Tucker M, Breitschwerdt E. Evaluation of conventional and real-time PCR assays for detection and differentiation of spotted fever group Rickettsia in dog blood. Vet Microbiol. 2008;129:294–303.
- Beall MJ, Chandrashekar R, Eberts MD, Cyr KE, Diniz PP, Mainville C, Serological and molecular prevalence of Borrelia burgdorferi, Anaplasma phagocytophilum, and Ehrlichia species in dogs from Minnesota. Vector Borne Zoonotic Dis. 2008;8:455–64.
- Diniz PP, Maggi RG, Schwartz DS, Cadenas MB, Bradley JM, Hegarty B, Canine bartonellosis: serological and molecular prevalence in Brazil and evidence of co-infection with Bartonella henselae and Bartonella vinsonii subsp. berkhoffii. Vet Res. 2007;38:697–710.
- Duncan AW, Maggi RG, Breitschwerdt EB. A combined approach for the enhanced detection and isolation of Bartonella species in dog blood samples: pre-enrichment liquid culture followed by PCR and subculture onto agar plates. J Microbiol Methods. 2007;69:273–81.
- Breitschwerdt EB, Maggi RG, Duncan AW, Nicholson WL, Hegarty BC, Woods CW. Bartonella species in blood of immunocompetent persons with animal and arthropod contact. Emerg Infect Dis. 2007;13:938–41.
- Jacomo V, Kelly PJ, Raoult D. Natural history of Bartonella infections (an exception to Koch’s postulate). Clin Diagn Lab Immunol. 2002;9:8–18.
- Billeter SA, Levy MG, Chomel BB, Breitschwerdt EB. Vector transmission of Bartonella species with emphasis on the potential for tick transmission. Med Vet Entomol. 2008;22:1–15.
- Billeter SA, Miller MK, Breitschwerdt EB, Levy MG. Detection of two Bartonella tamiae-like sequences in Amblyomma americanum (Acari: Ixodidae) using 16S–23S intergenic spacer region-specific primers. J Med Entomol. 2008;45:176–9.
- Meghari S, Rolain JM, Grau GE, Platt E, Barrassi L, Mege JL, Antiangiogenic effect of erythromycin: an in vitro model of Bartonella quintana infection. J Infect Dis. 2006;193:380–6.
- Biswas S, Raoult D, Rolain JM. Molecular characterization of resistance to macrolides in Bartonella henselae. Antimicrob Agents Chemother. 2006;50:3192–3.
- Biswas S, Raoult D, Rolain JM. Molecular mechanisms of resistance to antibiotics in Bartonella bacilliformis. J Antimicrob Chemother. 2007;59:1065–70.
- Breitschwerdt EB, Maggi RG, Nicholson WL, Cherry NA, Woods CW. Bartonella spp. bacteremia in patients with neurological and neuro-cognitive dysfunction. J Clin Microbiol. 2008;46:2856–61.
- Breitschwerdt EB, Maggi RG, Sigmon B, Nicholson WL. Isolation of Bartonella quintana from a woman and a cat following putative bite transmission. J Clin Microbiol. 2007;45:270–2.
- Maggi RG, Kosoy M, Mintzer M, Breitschwerdt EB. Isolation of Candidatus Bartonella melophagi from human blood. Emerg Infect Dis. 2009;15:66–8.
- Pappalardo BL, Brown T, Gebhardt D, Sontakke S, Breitschwerdt EB. Cyclic CD8+ lymphopenia in dogs experimentally infected with Bartonella vinsonii subsp. berkhoffii. Vet Immunol Immunopathol. 2000;75:43–57.
- Pappalardo BL, Brown TT, Tompkins M, Breitschwerdt EB. Immunopathology of Bartonella vinsonii (berkhoffii) in experimentally infected dogs. Vet Immunol Immunopathol. 2001;83:125–47.
- Popa C, Abdollahi-Roodsaz S, Joosten LA, Takahashi N, Sprong T, Matera G, Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4. Infect Immun. 2007;75:4831–7.
- Mexas AM, Hancock SI, Breitschwerdt EB. Bartonella henselae and Bartonella elizabethae as potential canine pathogens. J Clin Microbiol. 2002;40:4670–4.
- Maggi RG, Duncan AW, Breitschwerdt EB. Novel chemically modified liquid medium that will support the growth of seven Bartonella species. J Clin Microbiol. 2005;43:2651–5.
- Breitschwerdt EB, Kordick DL. Bartonella infection in animals: carriership, reservoir potential, pathogenicity, and zoonotic potential for human infection. Clin Microbiol Rev. 2000;13:428–38.
- Chomel BB, Boulouis HJ, Breitschwerdt EB. Cat scratch disease and other zoonotic Bartonella infections. J Am Vet Med Assoc. 2004;224:1270–9.
- Chomel BB, Boulouis HJ, Maruyama S, Breitschwerdt EB. Bartonella spp. in pets and effect on human health. Emerg Infect Dis. 2006;12:389–94.
- Maggi RG, Chomel B, Hegarty BC, Henn J, Breitschwerdt EB. A Bartonella vinsonii berkhoffii typing scheme based upon 16S–23S ITS and Pap31 sequences from dog, coyote, gray fox, and human isolates. Mol Cell Probes. 2006;20:128–34.
- Dehio C. Bartonella interactions with endothelial cells and erythrocytes. Trends Microbiol. 2001;9:279–85.
- Mandle T, Einsele H, Schaller M, Neumann D, Vogel W, Autenrieth IB, Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B. henselae. Blood. 2005;106:1215–22.
- Duncan AW, Marr HS, Birkenheuer AJ, Maggi RG, Williams LE, Correa MT, Bartonella DNA in the blood and lymph nodes of golden retrievers with lymphoma and in healthy controls. J Vet Intern Med. 2008;22:89–95.
- Maman E, Bickels J, Ephros M, Paran D, Comaneshter D, Metzkor-Cotter E, Musculoskeletal manifestations of cat scratch disease. Clin Infect Dis. 2007;45:1535–40.
- Giladi M, Maman E, Paran D, Bickels J, Comaneshter D, Avidor B, Cat-scratch disease-associated arthropathy. Arthritis Rheum. 2005;52:3611–7.
- Diniz PP, Wood M, Maggi RG, Sontakke S, Stepnik M, Breithschwerdt EB. Co-isolation of Bartonella henselae and Bartonella vinsonii subsp. berkhoffii from blood, joint and subcutaneous seroma fluids from two naturally infected dogs. Vet Microbiol. 2009;138:368–72.
- Harvey RA, Misselbeck WJ, Uphold RE. Cat-scratch disease: an unusual cause of combative behavior. Am J Emerg Med. 1991;9:52–3.
- Schaller JL, Burkland GA, Do Langhoff PJ. Bartonella infections cause agitation, panic disorder, and treatment-resistant depression? MedGenMed. 2007;9:54.
- King LJ, Anderson LR, Blackmore CG, Blackwell MJ, Lautner EA, Marcus LC, Executive summary of the AVMA One Health Initiative Task Force report. J Am Vet Med Assoc. 2008;233:259–61.
- Science CotNnfRiV. Critical needs for research in veterinary science. Committee on the National Needs for Research in Veterinary Science. Washington: National Research Council of the National Academies; 2001. p. 222.
- Table. PCR, blood, and CSF Bartonella spp. culture and serologic results from an 86-year-old man with recent onset arthritis, memory loss, and encephalopathy
Please use the form below to submit correspondence to the authors or contact them at the following address:
Edward B. Breitschwerdt, College of Veterinary Medicine, North Carolina State University, 4700 Hillsborough St, Research Bldg, Rm 454, Raleigh, NC 27606, USA
Comment submitted successfully, thank you for your feedback.
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
- Page created: December 09, 2010
- Page last updated: December 09, 2010
- Page last reviewed: December 09, 2010
- Centers for Disease Control and Prevention,
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
Office of the Director (OD)